BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9439039)

  • 1. Surveillance of invasive meningococcal disease in Canada, 1995-1996.
    Deeks S; Kertesz D; Ryan A; Johnson W; Ashton F
    Can Commun Dis Rep; 1997 Aug; 23(16):121-5. PubMed ID: 9439039
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of laboratories in population-based surveillance of invasive diseases in Lazio, Italy, 1998-2000.
    Faustini A; Fabrizi E; Sangalli M; Bordi E; Cipriani P; Fiscarelli E; Perucci CA
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):824-6. PubMed ID: 12461595
    [No Abstract]   [Full Text] [Related]  

  • 3. Neonatal meningococcal disease in the United States, 1990 to 1999.
    Shepard CW; Rosenstein NE; Fischer M;
    Pediatr Infect Dis J; 2003 May; 22(5):418-22. PubMed ID: 12792381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing patterns of case ascertainment and trends in meningococcal disease in England and Wales.
    Ramsay M; Kaczmarski E; Rush M; Mallard R; Farrington P; White J
    Commun Dis Rep CDR Rev; 1997 Apr; 7(4):R49-54. PubMed ID: 9127510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal disease in children hospitalized at six Canadian pediatric tertiary care centres.
    Gold R; Déry P; Halperin S; Law B; MacDonald N; Scheifele D; Marchessault V; Duclos P
    Can Commun Dis Rep; 1994 Jan; 20(2):9-11; discussion 11-2. PubMed ID: 8161973
    [No Abstract]   [Full Text] [Related]  

  • 6. Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.
    Squires SG; Pelletier L; Mungai M; Tsang R; Collins F; Stoltz J
    Can Commun Dis Rep; 2000 Nov; 26(21):177-82. PubMed ID: 11107657
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.
    Can Commun Dis Rep; 2006 Apr; 32(8):97-107. PubMed ID: 16685767
    [No Abstract]   [Full Text] [Related]  

  • 8. Outbreak of meningococcal disease in South Wales follows general increase in disease activity.
    Commun Dis Rep CDR Wkly; 1999 Feb; 9(7):57, 60. PubMed ID: 10098314
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of a cluster of cases of invasive group C Neisseria meningitidis infections in the Hamilton-Wentworth region--Ontario.
    Tolomeo O; Buffett C; Richardson E
    Can Commun Dis Rep; 1998 Aug; 24(15):122-6. PubMed ID: 9704541
    [No Abstract]   [Full Text] [Related]  

  • 10. Meningococcal disease: treatable but still terrifying.
    Munro R
    Intern Med J; 2002 Apr; 32(4):165-9. PubMed ID: 11951929
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal disease in Canada. Surveillance summary to 1987.
    Varughese PV; Carter AO
    Can Dis Wkly Rep; 1989 Apr; 15(17):89-96. PubMed ID: 2720807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in the incidence of invasive listeriosis in foodborne diseases active surveillance network sites, 1996-2003.
    Voetsch AC; Angulo FJ; Jones TF; Moore MR; Nadon C; McCarthy P; Shiferaw B; Megginson MB; Hurd S; Anderson BJ; Cronquist A; Vugia DJ; Medus C; Segler S; Graves LM; Hoekstra RM; Griffin PM;
    Clin Infect Dis; 2007 Feb; 44(4):513-20. PubMed ID: 17243053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual report of the Australian Meningococcal Surveillance Programme, 1998. The Australian Meningococcal Surveillance Programme.
    Commun Dis Intell; 1999 Nov; 23(12):317-23. PubMed ID: 10615794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 1999, through 31 December, 2001.
    Squires SG; Deeks SL; Tsang RS
    Can Commun Dis Rep; 2004 Feb; 30(3):17-28. PubMed ID: 14971276
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningococcal disease in Australia: 1997 and beyond.
    Harvey BM
    Commun Dis Intell; 1998 Jul; 22(7):134-5. PubMed ID: 9684531
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced surveillance of meningococcal disease in five English regions: first quarter 1998.
    Commun Dis Rep CDR Wkly; 1998 May; 8(21):183, 186. PubMed ID: 9635342
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of pneumococcal bloodstream infections.
    Rodríguez-Créixems M; Bertó J; Muñoz P; Alonso R; Alcalá L; Bouza E
    Pediatr Infect Dis J; 2003 Jul; 22(7):661-3. PubMed ID: 12886897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.